SorLA signaling by regulated intramembrane proteolysis

被引:60
作者
Boehm, Christopher
Seibel, Nicole M.
Henkel, Birgit
Steiner, Harald
Haass, Christian
Hampe, Wolfgang
机构
[1] Univ Hamburg, Med Ctr, Ctr Expt Med, Dept Biochem & Mol Biol 2 Mol Cell Biol, D-20246 Hamburg, Germany
[2] Univ Munich, Lab Alzheimers & Parkinsons Dis Res, Dept Biochem, Adolf Butenandt Inst, D-80336 Munich, Germany
关键词
D O I
10.1074/jbc.M601660200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The single-transmembrane receptor SorLA/LR11 contains binding domains typical for lipoprotein receptors and a VPS10 domain, which binds the neuropeptide head-activator. This undecapeptide enhances proliferation of neuronal precursor cells in a SorLA-dependent manner. Using specific inhibitors we found previously that head activator activates shedding of SorLA by the metalloprotease TACE close to the transmembrane domain releasing the large extracellular part of the receptor. Here we show that the remaining COOH-terminal membrane fragment of SorLA is processed by gamma-secretase. Inhibition of gamma-secretase by specific inhibitors or overexpression of dominant negative presenilin mutants and knock out of the presenilin genes led to accumulation of the SorLA membrane fragment and also of full-length SorLA in the membrane. In an in vitro assay we observed the gamma-secretase-dependent release of the two soluble cleavage products, the SorLA cytoplasmic domain and the SorLA gamma-peptide. These processing steps are reminiscent of a novel signaling pathway that has been described for the notch receptor. Here, the notch cytoplasmic domain is released into the cytoplasm by the gamma-secretase and migrates to the nucleus where it acts as a transcriptional regulator. In parallel we found that a fusion protein of the released cytoplasmic tail of SorLA with EGFP located to the nucleus only if the nuclear localization signal of SorLA was intact. In a reporter gene assay the cytoplasmic domain of SorLA acted as a transcriptional activator indicating that SorLA might directly regulate transcription after activation by gamma-secretase.
引用
收藏
页码:14547 / 14553
页数:7
相关论文
共 55 条
[1]   Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein [J].
Andersen, OM ;
Reiche, J ;
Schmidt, V ;
Gotthardt, M ;
Spoelgen, R ;
Behlke, J ;
von Arnim, CAF ;
Breiderhoff, T ;
Jansen, P ;
Wu, X ;
Bales, KR ;
Cappai, R ;
Masters, CL ;
Gliemann, J ;
Mufson, EJ ;
Hyman, BT ;
Paul, SM ;
Nykjær, A ;
Willnow, TE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (38) :13461-13466
[2]   Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent γ-secretase cleavage [J].
Berezovska, O ;
Jack, C ;
Deng, A ;
Gastineau, N ;
Rebeck, GW ;
Hyman, BT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30018-30023
[3]  
Boels K, 2001, J CELL SCI, V114, P3599
[4]   Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae [J].
Boucher, P ;
Liu, PS ;
Gotthardt, M ;
Hiesberger, T ;
Anderson, RGW ;
Herz, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :15507-15513
[5]   A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60 [J].
Cao, XW ;
Südhof, TC .
SCIENCE, 2001, 293 (5527) :115-120
[6]   Dissection of amyloid-β precursor protein-dependent transcriptional transactivation [J].
Cao, XW ;
Südhof, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :24601-24611
[7]   MUTATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN FAMILIAL ALZHEIMERS-DISEASE INCREASES BETA-PROTEIN PRODUCTION [J].
CITRON, M ;
OLTERSDORF, T ;
HAASS, C ;
MCCONLOGUE, L ;
HUNG, AY ;
SEUBERT, P ;
VIGOPELFREY, C ;
LIEBERBURG, I ;
SELKOE, DJ .
NATURE, 1992, 360 (6405) :672-674
[8]   Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line [J].
Dicou, E ;
Vincent, JP ;
Mazella, J .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 78 (01) :92-99
[9]   Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain [J].
Dovey, HF ;
John, V ;
Anderson, JP ;
Chen, LZ ;
Andrieu, PD ;
Fang, LY ;
Freedman, SB ;
Folmer, B ;
Goldbach, E ;
Holsztynska, EJ ;
Hu, KL ;
Johnson-Wood, KL ;
Kennedy, SL ;
Kholedenko, D ;
Knops, JE ;
Latimer, LH ;
Lee, M ;
Liao, Z ;
Lieberburg, IM ;
Motter, RN ;
Mutter, LC ;
Nietz, J ;
Quinn, KP ;
Sacchi, KL ;
Seubert, PA ;
Shopp, GM ;
Thorsett, ED ;
Tung, JS ;
Wu, J ;
Yang, S ;
Yin, CT ;
Schenk, DB ;
May, PC ;
Altstiel, LD ;
Bender, MH ;
Boggs, LN ;
Britton, TC ;
Clemens, JC ;
Czilli, DL ;
Dieckman-McGinty, DK ;
Droste, JJ ;
Fuson, KS ;
Gitter, BD ;
Hyslop, PA ;
Johnstone, EM ;
Li, WY ;
Little, SP ;
Mabry, TE ;
Miller, FD ;
Ni, B .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :173-181
[10]   Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD) [J].
Edbauer, D ;
Willem, M ;
Lammich, S ;
Steiner, H ;
Haass, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13389-13393